Manhard Kimberly's Form 4 filing
Inhibrx Biosciences, Inc. (INBX) · filed Sep 10, 2026
- Accession no.
- 0001202094-26-000004
- Filed
- Sep 10, 2026, 7:06 PM ET
- Trade date
- Sep 8-9, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $115.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Manhard KimberlyCIK 0001202094 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Common Stock | SSaleDisposed | −500 | $115.14 | −$57,570 | 9,500 | Indirect | |
| Sep 9, 2026 | Common Stock | SSaleDisposed | −500 | $115.80 | −$57,897.5 | 9,000 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.